查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405693

圆二色光谱仪：市场占有率分析、产业趋势与统计、成长预测，2024-2029 年

Circular Dichroism Spectrometers - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2024 - 2029
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

圆二色光谱仪市场预计在预测期（2024-2029年）复合年增长率为6.5%

G圆二色光谱仪-市场-IMG1

主要亮点

  • 由于各国为遏制病毒传播而实施的封锁规定，COVID-19 大流行最初对市场产生了重大影响，并影响了研发活动。然而，在大流行的后期，为了寻找 SARS-CoV-2 病毒感染的治疗方法，开展了非常深入的研究和开发工作，并使用圆二色光谱仪来检测蛋白质和 DNA 等生物分子。了解分子结构和掌性活性。
  • 例如，根据 2021 年 6 月发表在 NCBI 上的一项研究显示，圆二色性是生物化学、结构生物学和药物化学中的常用技术，广泛用于研究蛋白质结构和结构变化。因此，疫情的爆发加速了研究活动，增加了对圆二色光谱仪的需求。正因如此，市场在疫情期间呈现可观的成长。此外，大流行后，由于在 COVID-19 疫苗开发中更多地采用圆二色光强度，市场激增。
  • 生技药品的日益普及以及私营和公共部门对生技药品研究和开发的投资增加是推动市场成长的主要因素。圆二色光谱法用于研究生物分子的分子结构和掌性活性，其用途可用于治疗各种慢性和罕见疾病（例如疫苗）的生物製药或生技药品，预计随着普及和使用的不断增加而增加基因和细胞疗法、融合蛋白、胰岛素、干扰素、单株抗体（mAb 等）。
  • 例如，根据美国癌症协会 2022 年 4 月的报告，生技药品以多种方式用于治疗癌症，并广泛用于治疗。此外，2022年6月，安进宣布其Rituxan生物仿製药RIABNI（rituximab marx）经美国食品药物管理局核准，以一种或多种肿瘤坏死因子（TNF）拮抗与甲氨蝶呤联合治疗时无效。患有中度至重度活动性类风湿性关节炎（RA）的患者。因此，生技药品的使用日益增加及其在治疗各种疾病中的潜力预计将增加圆二色光谱仪用于生物分子分析的密集研究和开发活动。因此，预计对圆二色光谱仪的需求在预测期内增加，预计将推动研究市场的成长。
  • 此外，不断增加的研发活动以及政府和私人实体对该领域的新投资预计将在预测期内推动圆二色光谱仪市场的成长。例如，2022年8月，中国信达生物和总部位于巴黎的赛诺菲将向生物製药集团投资24.2亿美元，在中国共同开发两种抗癌药物。据信达生物介绍，SAR408701（tusamitamab ravtansine）用于治疗肺癌、胃癌等，SAR444245（non-alpha IL-2）针对皮肤癌、头颈肿瘤等正在进行II期试验。 。
  • 同样在 2022 年 6 月，Astra Zeneca旗下罕见疾病部门 Alexion 宣布将投资约 6,500 万欧元（6,860 万美元）扩大其在爱尔兰的生产能力，该公司计划透过这笔投资提高其生技药品生产能力并加强在该国的研究和开发倡议。因此，由于上述因素，圆二色光谱仪的需求预计将增加，并预计在预测期内出现可观的市场成长。
  • 因此，增加对生技药品製剂和生物製药市场开拓的投资，以及增加私营和公共部门对研发的投资，预计将成为推动市场成长的因素。然而，在预测期内，缺乏熟练的专业人员预计将限制圆二色光谱仪市场的成长。

圆二色光谱仪市场趋势

预计医药产业在预测期内将健康成长

  • 由于製药业广泛参与生技药品和其他药物分子的研发活动，因此成为各种分析仪器的最大最终用户之一。因此，圆二色光谱仪在製药公司中的使用将会增加，市场预计将会成长。
  • 例如，根据英国国家统计局 (ONS) 2021 年 11 月的报告，英国製药业的年度研发支出成长 6%，达到 50.2 亿英镑（59.9 亿美元），创历史新高。这约占英国研发支出总额的18.6%。
  • 此外，圆二色光谱仪在生物製药分析开发中的重要性预计将推动该领域的成长。例如，根据 JASCO Corporation 发表的一项研究，圆二色性 (CD) 测量可以提供有关少量样品中蛋白质结构变化的资讯。由于蛋白质结构和活性密切相关，CD 测量被广泛接受用于蛋白质（包括生物製药）的品管。由于製药业对圆二色光谱仪的需求增加，此类研究正在推动该领域的发展。
  • 此外，该领域主要市场参与者增加对药物研发活动的投资预计将进一步增加对圆二色光谱仪的需求并促进该领域的成长。例如，2022年5月，辉瑞投资约2,000万美元在印度马德拉斯印度理工学院（IIT）推出全球医药研发中心。因此，由于上述因素，预计製药业在预测期内将在调查市场中占据重要份额。
  • 因此，由于上述因素，预计在预测期内该细分市场将出现相当大的成长。
G圆二色光谱仪-市场-IMG2

预计在预测期内，北美将占据圆二色光谱仪市场的主要份额

  • 由于製药业广泛参与生技药品和其他药物分子的研发活动，因此成为各种分析仪器的最大最终用户之一。因此，圆二色光谱仪在製药公司中的使用将会增加，市场预计将会成长。
  • 例如，英国国家统计局（ONS）2021年11月报告称，英国英国业的年度研发支出增长6%，达到50.2亿英镑（59.9亿美元），创历史最高水平，约占总额的18.6%英国研发支出。
  • 此外，圆二色光谱仪在生物製药分析开发中的重要性预计将推动该领域的成长。例如，根据 JASCO Corporation 发表的一项研究，圆二色性 (CD) 测量可以提供有关少量样品中蛋白质结构变化的资讯。由于蛋白质结构和活性密切相关，CD 测量被广泛接受用于蛋白质（包括生物製药）的品管。由于製药业对圆二色光谱仪的需求增加，此类研究正在推动该领域的发展。
  • 此外，该领域主要市场参与者增加对药物研发活动的投资预计将进一步增加对圆二色光谱仪的需求并促进该领域的成长。例如，2022年5月，辉瑞投资约2,000万美元在印度马德拉斯印度理工学院（IIT）推出全球医药研发中心。因此，由于上述因素，预计製药业在预测期内将在调查市场中占据很大份额。
  • 因此，由于上述因素，预计在预测期内该细分市场将出现相当大的成长。

圆二色光谱仪产业概况

圆二色光谱仪市场已整合，并由几个主要企业组成。竞争形势包括多家拥有市场占有率的国际知名公司，包括 Jasco、Applied Photophysicals Ltd.、On-Line Instrument Systems, Inc. (Olis)、Bruker 和 Bio-Logic Sc​​ience Instrument, Inc.。当地企业。

其他福利：

  • Excel 格式的市场预测 (ME) 表
  • 3 个月分析师支持

目录

第一章简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场动态

  • 市场概况
  • 市场驱动因素
    • 生技药品日益普及
    • 增加私营和公共部门对生物製药研发的投资
  • 市场抑制因素
    • 需要专门的基础设施和熟练的操作员
  • 波特五力分析
    • 新进入者的威胁
    • 买家/消费者的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间敌对关係的强度

第五章市场区隔（市场规模，以金额为准）

  • 副产品
    • 线偏振光源
    • 圆偏振光源
    • 多个光源
  • 按最终用户
    • 製药业
    • 政府/私人研究机构
    • 其他最终用户
  • 按地区
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 义大利
      • 西班牙
      • 其他欧洲国家
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 韩国
      • 其他亚太地区
    • 中东/非洲
      • GCC
      • 南非
      • 其他中东和非洲
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地区

第六章竞争形势

  • 公司简介
    • Jasco
    • Applied Photophysics Ltd.
    • On-Line Instrument Systems, Inc.（Olis）
    • Bruker
    • Bio-Logic Science Instrument, Inc
    • A.KRUSS Optronic GmbH
    • Hinds Instruments, Inc.

第七章 市场机会及未来趋势

简介目录
Product Code: 67799
GCircular Dichroism Spectrometers - Market - IMG1

The GCircular Dichroism Spectrometers Market is expected to register a CAGR of 6.5% during the forecast period(2024-2029).

Key Highlights

  • The COVID-19 pandemic significantly impacted the market initially due to the lockdown restrictions imposed by the countries to control the spread of the virus, thereby impacting research and development activities. But during the late pandemic, very intensive research and development activities were started to find a cure for SARS-CoV-2 virus infection in which circular dichroism spectrometers were also used for the understanding of the molecular structure and chiral activities of biomolecules such as protein and DNA.
  • For instance, according to the research study published in June 2021 in NCBI, circular dichroism is a common technique in biochemistry, structural biology, and pharmaceutical chemistry, and it is a widely used method for examining the structures and conformational changes of proteins. Therefore, the outbreak of the pandemic increased research activities, which in turn propelled the demand for circular dichroism spectrometers. Thus, the market witnessed considerable growth during the pandemic. Furthermore, the market has seen a surge post-pandemic due to the increased adoption of circular dichroism spectrophotometers in the development of vaccines for COVID-19.
  • The increasing popularity of biologics and increasing investments by private and public sectors in the R&D of biopharmaceuticals are the major factors propelling the market growth. The circular dichroism spectrometers are used in the study of molecular structure and chiral activities of biomolecules, and their use is expected to increase with the growing popularity and usage of biopharmaceuticals or biologics (for example, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) among others) that are used in the treatment of various chronic and rare diseases.
  • For instance, according to the April 2022 report of the American Cancer Society, biologics are used in the treatment of cancer in many ways and are being used widely for the treatment. Furthermore, in June 2022, Amgen Inc. received approval for RIABNI (rituximab-Marx), a biosimilar to Rituxan, from the United States Food and Drug Administration for adults with moderate to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies in combination with methotrexate. Hence, the growing usage of biologics drugs and their potential in treating various diseases is expected to increase intensive research and development activities, where circular dichroism spectrometers are used in the analysis of biomolecules, and thus, the demand for circular dichroism spectrometers is expected to increase over the forecast period that is expected to boost growth in the studied market.
  • Moreover, the growing research and development activities, along with new investments in the area by the government as well as private entities, are expected to fuel growth in the circular dichroism spectrometers market over the forecast period. For instance, in August 2022, Innovent Biologics of China and Paris-based Sanofi would invest USD 2.42 billion in the biopharma group to jointly develop two cancer drugs in China. As per Innovent Biologics, SAR408701, or tusamitamab ravtansine, would be used to treat lung, gastric, and other cancers, while SAR444245, or non-alpha IL-2, was under phase-II studies for skin cancer, head, and neck tumors, among others.
  • In addition, in June 2022, the Rare Disease division of AstraZeneca, Alexion, spent about EUR 65 million (USD 68.6 million) to expand its manufacturing capabilities in Ireland, and over the next 18 months, the investment will be used by the company to build up its biologics manufacturing capacity and increase research and development initiatives in the country. Therefore, due to the above-mentioned factors, the demand for circular dichroism spectrometers is expected to increase; thereby considerable market growth is anticipated over the forecast period.
  • Therefore, the rising investments in the development of biologics and biopharmaceuticals, along with the increasing investments by private and public sectors in R&D, are the factors expected to drive the market growth. However, the lack of skilled professionals is expected to restrain the growth of the circular dichroism spectrometers market over the forecast period.

Circular Dichroism Spectrometers Market Trends

Pharmaceutical Industry is Expected to Witness Healthy Growth Over the Forecast Period

  • The pharmaceutical industry is one of the largest end-users of various analytical instruments as they are intensively involved in the research and development activities of biologics and other drug molecules; hence, the use of circular dichroism spectrometers is expected to increase among the pharmaceutical companies, and the market is expected to grow.
  • For instance, according to the November 2021 report of the Office for National Statistics (ONS) of the United Kingdom, the amount spent on research and development annually in the pharmaceutical industry in the United Kingdom has increased by 6% to an all-time high of GBP 5.02 billion (USD 5.99 billion), which is about 18.6 of the total research and development spending of the United Kingdom.
  • Furthermore, the importance of circular dichroism spectrometers in the analytical development of biopharmaceuticals is expected to drive segment growth. For instance, according to the study published by JASCO Corporation, circular dichroism (CD) measurements can provide information regarding changes in protein structure in small quantities of samples. Since protein structure and activity are closely related, CD measurements are widely accepted in the quality control of protein, which includes biomedicines. Such studies propel the segment growth due to increased demand for circular dichroism spectrometers in the pharmaceutical industry.
  • Moreover, the growing investment in drug research and development activities by the key market players in the area is further expected to increase the demand for circular dichroism spectrometers, which is expected to boost the segment's growth. For instance, in May 2022, Pfizer Inc. launched a global drug research and development center at the Indian Institute of Technology (IIT) Madras, India, with an investment of about USD 20.0 million. Therefore, due to the aforementioned factors, the pharmaceutical industry is expected to hold a significant share of the studied market over the forecast period.
  • Therefore, owing to the above-mentioned factors, considerable segment growth is anticipated over the forecast period.
GCircular Dichroism Spectrometers - Market - IMG2

North America is Expected to Hold a Significant Share in the Circular Dichroism Spectrometers Market Over the Forecast Period

  • The pharmaceutical industry is one of the largest end-users of various analytical instruments as they are intensively involved in the research and development activities of biologics and other drug molecules; hence, the use of circular dichroism spectrometers is expected to increase among the pharmaceutical companies, and the market is expected to grow.
  • For instance, according to the November 2021 report of the Office for National Statistics (ONS) of the United Kingdom, the amount spent on research and development annually in the pharmaceutical industry in the United Kingdom has increased by 6% to an all-time high of GBP 5.02 billion (USD 5.99 billion), which is about 18.6 of the total research and development spending of the United Kingdom.
  • Furthermore, the importance of circular dichroism spectrometers in the analytical development of biopharmaceuticals is expected to drive segment growth. For instance, according to the study published by JASCO Corporation, circular dichroism (CD) measurements can provide information regarding changes in protein structure in small quantities of samples. Since protein structure and activity are closely related, CD measurements are widely accepted in the quality control of protein, which includes biomedicines. Such studies propel the segment growth due to increased demand for circular dichroism spectrometers in the pharmaceutical industry.
  • Moreover, the growing investment in drug research and development activities by the key market players in the area is further expected to increase the demand for circular dichroism spectrometers, which is expected to boost the segment's growth. For instance, in May 2022, Pfizer Inc. launched a global drug research and development center at the Indian Institute of Technology (IIT) Madras, India, with an investment of about USD 20.0 million. Therefore, due to the aforementioned factors, the pharmaceutical industry is expected to hold a significant share of the studied market over the forecast period.
  • Therefore, owing to the above-mentioned factors, considerable segment growth is anticipated over the forecast period.

Circular Dichroism Spectrometers Industry Overview

The circular dichroism spectrometers market is consolidated and consists of a few major players. The factors owing to the competition include competitive landscape includes an analysis of a few international as well as local companies that hold the market shares and are well known, including Jasco, Applied Photophysics Ltd., On-Line Instrument Systems, Inc. (Olis), Bruker, and Bio-Logic Science Instrument, Inc. among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Defination
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Popularity of Biologics
    • 4.2.2 Increasing Investments by Private and Public Sectors in R&D of Biopharmaceuticals
  • 4.3 Market Restraints
    • 4.3.1 Requirement of Specialized Infrastructure and Skilled Operators
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product
    • 5.1.1 Linearly Polarized Light Sources
    • 5.1.2 Circularly Polarized Light Sources
    • 5.1.3 Multiple Light Sources
  • 5.2 By End-User
    • 5.2.1 Pharmaceutical Industry
    • 5.2.2 Government and Private Research Organizations
    • 5.2.3 Other End-Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Jasco
    • 6.1.2 Applied Photophysics Ltd.
    • 6.1.3 On-Line Instrument Systems, Inc. (Olis)
    • 6.1.4 Bruker
    • 6.1.5 Bio-Logic Science Instrument, Inc
    • 6.1.6 A.KRUSS Optronic GmbH
    • 6.1.7 Hinds Instruments, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS